These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 9693398

  • 1. A randomized controlled double-blind study of the effects on hemostasis of two progestogen-only pills containing 75 microgram desogestrel or 30 microgram levonorgestrel.
    Winkler UH, Howie H, Bühler K, Korver T, Geurts TB, Coelingh Bennink HJ.
    Contraception; 1998 Jun; 57(6):385-92. PubMed ID: 9693398
    [Abstract] [Full Text] [Related]

  • 2. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA, Bonnar J.
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [Abstract] [Full Text] [Related]

  • 3. Effects on hemostasis after two-year use of low dose combined oral contraceptives with gestodene or levonorgestrel.
    Prasad RN, Koh SC, Viegas OA, Ratnam SS.
    Clin Appl Thromb Hemost; 1999 Jan; 5(1):60-70. PubMed ID: 10725985
    [Abstract] [Full Text] [Related]

  • 4. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives.
    Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN.
    Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462
    [Abstract] [Full Text] [Related]

  • 5. Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 micrograms ethinyl estradiol and 2.00 mg dienogest on the hemostatic system.
    Spona J, Feichtinger W, Kindermann C, Schneider B, Mellinger U, Walter F, Moore C, Gräser T.
    Contraception; 1997 Aug; 56(2):67-75. PubMed ID: 9315414
    [Abstract] [Full Text] [Related]

  • 6. Effect of four oral contraceptives on hemostatic parameters.
    Wiegratz I, Lee JH, Kutschera E, Winkler UH, Kuhl H.
    Contraception; 2004 Aug; 70(2):97-106. PubMed ID: 15288212
    [Abstract] [Full Text] [Related]

  • 7. Effects on hemostatic variables of desogestrel- and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: a review.
    Winkler UH.
    Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S51-61. PubMed ID: 9753311
    [Abstract] [Full Text] [Related]

  • 8. Comparison of the lipoprotein, carbohydrate, and hemostatic effects of phasic oral contraceptives containing desogestrel or levonorgestrel.
    Knopp RH, Broyles FE, Cheung M, Moore K, Marcovina S, Chandler WL.
    Contraception; 2001 Jan; 63(1):1-11. PubMed ID: 11257242
    [Abstract] [Full Text] [Related]

  • 9. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM, Algra A, Meijers JC, Bouma BN, Grobbee DE.
    Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850
    [Abstract] [Full Text] [Related]

  • 10. A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 micrograms and 30 micrograms ethinylestradiol.
    Winkler UH, Schindler AE, Endrikat J, Düsterberg B.
    Contraception; 1996 Feb; 53(2):75-84. PubMed ID: 8838483
    [Abstract] [Full Text] [Related]

  • 11. Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM, Algra A, Meijers JC, Bouma BN, Grobbee DE.
    Blood Coagul Fibrinolysis; 2002 Jul; 13(5):373-81. PubMed ID: 12138364
    [Abstract] [Full Text] [Related]

  • 12. The effects of seven monophasic oral contraceptive regimens on hemostatic variables: conclusions from a large randomized multicenter study.
    Oral Contraceptive and Hemostasis Study Group.
    Contraception; 2003 Mar; 67(3):173-85. PubMed ID: 12618251
    [Abstract] [Full Text] [Related]

  • 13. Hemostasis profile and lipid metabolism with long-interval use of a desogestrel-containing oral contraceptive.
    Cachrimanidou AC, Hellberg D, Nilsson S, von Schoulz B, Crona N, Siegbahn A.
    Contraception; 1994 Aug; 50(2):153-65. PubMed ID: 7956214
    [Abstract] [Full Text] [Related]

  • 14. A cross-over study of three oral contraceptives containing ethinyloestradiol and either desogestrel or levonorgestrel.
    Song S, Chen JK, Yang PJ, He ML, Li LM, Fan BC, Rekers H, Fotherby K.
    Contraception; 1992 Jun; 45(6):523-32. PubMed ID: 1535580
    [Abstract] [Full Text] [Related]

  • 15. A double-blind study comparing the contraceptive efficacy, acceptability and safety of two progestogen-only pills containing desogestrel 75 micrograms/day or levonorgestrel 30 micrograms/day. Collaborative Study Group on the Desogestrel-containing Progestogen-only Pill.
    Eur J Contracept Reprod Health Care; 1998 Dec; 3(4):169-78. PubMed ID: 10036599
    [Abstract] [Full Text] [Related]

  • 16. An open label, randomized study to evaluate the effects of seven monophasic oral contraceptive regimens on hemostatic variables. Outline of the protocol. Oral Contraceptive and Hemostasis Study Group.
    Contraception; 1999 Jun; 59(6):345-55. PubMed ID: 10518228
    [Abstract] [Full Text] [Related]

  • 17. Third-generation progestogen type influences hemostatic changes caused by oral contraceptives in Brazilian women.
    Ferreira AC, Montes MB, Franceschini SA, Toloi MR.
    Contraception; 2001 Dec; 64(6):353-6. PubMed ID: 11834233
    [Abstract] [Full Text] [Related]

  • 18. The effects of two progrestogen-only pills containing either desogestrel (75 microgram/day) or levonorgestrel (30 microgram/day) on carbohydrate metabolism and adrenal and thyroid function.
    Kivelä A, Ruuskanen M, Agren U, Dieben T.
    Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):71-7. PubMed ID: 11518451
    [Abstract] [Full Text] [Related]

  • 19. Effects of three low-dose oral contraceptive formulations on lipid metabolism.
    Bertolini S, Elicio N, Cordera R, Gapitanio GL, Montagna G, Croce S, Saturnino M, Balestreri R, De Cecco L.
    Acta Obstet Gynecol Scand; 1987 Jun; 66(4):327-32. PubMed ID: 2962417
    [Abstract] [Full Text] [Related]

  • 20. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.
    Middeldorp S, Meijers JC, van den Ende AE, van Enk A, Bouma BN, Tans G, Rosing J, Prins MH, Büller HR.
    Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.